Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Treatments containing an artemisinin derivative (artemisinin-combination therapies
The modulation of this Raf/MEK/ERK pathway has been reported as a useful approach to treate proliferative disorders such as cancer
Melanin precursor 5
01-10 μg/mL) causes cell shrinage
H-Val-Tyr-OH 27708 Treatments containing an artemisinin derivativeH Val Tyr OH is an endogenous metabolite. Product information CAS Number: 3061 91 4 Molecular Weight: 280. 32 Formula: C14H20N2O4 Chemical Name: (2S) 2 [(2S) 2 amino 3 methylbutanamido] 3 (4 hydroxyphenyl)propanoic acid Smiles: CC(C)[C@H](N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O InChiKey: VEYJKJORLPYVLO RYUDHWBXSA N InChi: InChI=1S C14H20N2O4 c1 8(2)12(15)13(18)16 11(14(19)20)7 9 3 5 10(17)6 4 9 h3 6,8,11 12,17H,7,15H2,1 2H3,(H,16,18)(H,19,20) t11 ,12 m0